Trial Profile
Liraglutide in type 2 diabetic patients and non-alcoholic fatty liver disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 31 Aug 2015
Price :
$35
*
At a glance
- Drugs Liraglutide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Pharmacodynamics; Therapeutic Use
- 31 Aug 2015 New trial record